Antibody Discovery Market to Reach USD 15.84 Billion by 2034 Driven by AI Platforms & Rising Biologics Pipelines

Pune, India - December 2025 - The global Antibody Discovery Market, valued at USD 6.12 billion in 2024, is projected to reach USD 15.84 billion by 2034, growing at an impressive 9.9% CAGR (2025-2034), according to Exactitude Consultancy. The market is expanding rapidly as pharmaceutical and biotechnology companies accelerate the development of monoclonal antibodies, bispecifics, antibody-drug conjugates (ADCs), and next-generation therapeutic antibodies.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73147

Market Summary
The Antibody Discovery Market is experiencing strong growth due to increasing demand for targeted therapeutics, rising biologics approvals, and advancements in discovery technologies such as AI-driven antibody design, phage display, hybridoma development, yeast display, transgenic animal platforms, and single-cell screening techniques.

With oncology, autoimmune disorders, infectious diseases, and rare diseases dominating the therapeutic landscape, antibody-based drugs remain one of the most promising classes of biologics. CROs and biotech companies are increasingly outsourcing discovery workflows to speed up lead identification and reduce R&D costs. North America holds the largest market share, while Asia-Pacific is the fastest-growing region, supported by expanding biologics manufacturing, government incentives, and rising investments in antibody research.

Key Takeaways
• 2024 Market Size: USD 6.12 Billion
• 2034 Forecast: USD 15.84 Billion
• CAGR: 9.9% (2025-2034)
• AI-powered antibody design platforms gaining global adoption
• Increasing focus on bispecific antibodies & ADC pipelines
• Rising outsourcing to antibody discovery CROs

Explore Full Report here:
https://exactitudeconsultancy.com/reports/73147/antibody-discovery-market

Market Drivers
• Growing prevalence of cancer and autoimmune diseases
• Rising investments in biologics and immunotherapy
• Adoption of high-throughput discovery technologies
• Expansion of AI/ML tools for antibody sequence optimization
• Increase in partnerships between pharma & biotech companies

Segmentation Snapshot
By Technology
• Phage Display
• Hybridoma Technology
• Yeast Display
• Transgenic Animal Platforms
• Single-Cell Analysis
• AI/Computational Antibody Design

By Drug Type
• Monoclonal Antibodies
• Bispecific Antibodies
• Antibody-Drug Conjugates (ADCs)
• Fragments & Recombinant Antibodies

By Application
• Oncology
• Autoimmune Diseases
• Infectious Diseases
• Neurology
• Others

By End User
• Pharmaceutical & Biotechnology Companies
• CROs & Research Laboratories
• Academic Institutes

By Region
• North America (Largest Share)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73147

Recent Developments
• AI-enabled antibody discovery platforms adopted by major pharma companies.
• Growing number of bispecific antibody and ADC pipeline collaborations.
• CROs expanding high-throughput screening capabilities for faster lead selection.

Expert Quote - Irfan Tamboli, Business Development Executive
"Antibody discovery is entering a new era where AI, automation, and high-throughput platforms are dramatically accelerating therapeutic innovation. Companies leveraging these technologies will dominate the next wave of biologics development."

Conclusion
The Antibody Discovery Market is set for robust growth through 2034 as demand for precision immunotherapies rises worldwide. Integrated discovery platforms, AI-enabled design tools, and specialized CRO partnerships will play a pivotal role in shaping the future of biologics pipelines.

This report is also available in the following languages : Japanese (抗体発見市場), Korean (항체 발견 시장), Chinese (抗体发现市场), French (Marché de la découverte d'anticorps), German (Markt für Antikörperforschung), and Italian (Mercato della scoperta degli anticorpi), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73147

Our More Reports:

Biologics Fill Finish Manufacturing Market
https://exactitudeconsultancy.com/reports/73133/biologics-fill-finish-manufacturing-market

Clinical Trial Services Market
https://exactitudeconsultancy.com/reports/73135/clinical-trial-services-market

Biologics Contract Manufacturing Market
https://exactitudeconsultancy.com/reports/73137/biologics-contract-manufacturing-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.